Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy
Abstract
:1. Introduction
2. Materials and Methods
2.1. Cells and Cell Culture
2.2. Myotube Differentiation
2.3. Electrical Pulse Stimulation Culture during Myotube Differentiation
2.4. Immunostaining
2.5. Morphological Analysis
2.6. Measurement of Myotube Contractile Activity
2.7. Apoptosis Analysis
2.8. Addition of Ca2+ Chelator
2.9. Addition of Bax Inhibitor
2.10. Statistical Analysis
3. Results
3.1. Retinoic Acid Induces the Differentiation of Human iPS Cells into Myotubes
3.2. Electrical Pulse Stimulation Culture Improves the Contractile Function of Myotubes
3.3. iPS-Derived Myotube Apoptosis in Electrical Pulse Stimulation Cultures
3.4. Apoptosis Is Suppressed by Chelating Ca2+
3.5. Apoptosis Is Suppressed by Inhibiting the Bax Pathway
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Birnkrant, D.J.; Bushby, K.; Bann, C.M.; Apkon, S.D.; Blackwell, A.; Brumbaugh, D.; Case, L.E.; Clemens, P.R.; Hadjiyannakis, S.; Pandya, S.; et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018, 17, 251–267. [Google Scholar] [CrossRef] [Green Version]
- Govoni, A.; Magri, F.; Brajkovic, S.; Zanetta, C.; Faravelli, I.; Corti, S.; Bresolin, N.; Comi, G.P. Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy. Cell. Mol. Life Sci. 2013, 70, 4585–4602. [Google Scholar] [CrossRef] [PubMed]
- Koeks, Z.; Bladen, C.L.; Salgado, D.; van Zwet, E.; Pogoryelova, O.; McMacken, G.; Monges, S.; Foncuberta, M.E.; Kekou, K.; Kosma, K.; et al. Clinical outcomes in Duchenne muscular dystrophy: A study of 5345 patients from the TREAT-NMD DMD global database. J. Neuromuscul. Dis. 2017, 4, 293–306. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hoffman, E.P.; Brown, R.H., Jr.; Kunkel, L.M. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51, 919–928. [Google Scholar] [CrossRef]
- Bladen, C.L.; Salgado, D.; Monges, S.; Foncuberta, M.E.; Kekou, K.; Kosma, K.; Dawkins, H.; Lamont, L.; Roy, A.J.; Chamova, T.; et al. The TREAT-NMD DMD global database: Analysis of more than 7000 Duchenne muscular dystrophy mutations. Hum. Mutat. 2015, 36, 395–402. [Google Scholar] [CrossRef] [PubMed]
- Bulfield, G.; Siller, W.G.; Wight, P.A.; Moore, K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 1984, 81, 1189–1192. [Google Scholar] [CrossRef] [Green Version]
- Sicinski, P.; Geng, Y.; Ryder-Cook, A.S.; Barnard, E.A.; Darlison, M.G.; Barnard, P.J. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation. Science 1989, 244, 1578–1580. [Google Scholar] [CrossRef]
- Li, H.L.; Fujimoto, N.; Sasakawa, N.; Shirai, S.; Ohkame, T.; Sakuma, T.; Tanaka, M.; Amano, N.; Watanabe, A.; Sakurai, H.; et al. Precise correction of the dystrophin gene in Duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. Stem Cell Rep. 2015, 4, 143–154. [Google Scholar] [CrossRef] [Green Version]
- Shoji, E.; Sakurai, H.; Nishino, T.; Nakahata, T.; Heike, T.; Awaya, T.; Fujii, N.; Manabe, Y.; Matsuo, M.; Sehara-Fujisawa, A. Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells. Sci. Rep. 2015, 5, 12831. [Google Scholar] [CrossRef] [Green Version]
- Tanaka, A.; Woltjen, K.; Miyake, K.; Hotta, A.; Ikeya, M.; Yamamoto, T.; Nishino, T.; Shoji, E.; Sehara-Fujisawa, A.; Manabe, Y.; et al. Efficient and reproducible myogenic differentiation from human iPS cells: Prospects for modeling Miyoshi Myopathy in vitro. PLoS ONE 2013, 8, e61540. [Google Scholar] [CrossRef]
- Uchimura, T.; Otomo, J.; Sato, M.; Sakurai, H. A human iPS cell myogenic differentiation system permitting high-throughput drug screening. Stem Cell Res. 2017, 25, 98–106. [Google Scholar] [CrossRef]
- Rudnicki, M.A.; Schnegelsberg, P.N.; Stead, R.H.; Braun, T.; Arnold, H.H.; Jaenisch, R. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993, 75, 1351–1359. [Google Scholar] [CrossRef]
- Gossen, M.; Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 1992, 89, 5547–5551. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jinek, M.; Chylinski, K.; Fonfara, I.; Hauer, M.; Doudna, J.A.; Charpentier, E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012, 337, 816–821. [Google Scholar] [CrossRef]
- Ikeda, K.; Ito, A.; Imada, R.; Sato, M.; Kawabe, Y.; Kamihira, M. In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model. Sci. Rep. 2017, 7, 44570. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yoshioka, K.; Ito, A.; Arifuzzaman, M.; Yoshigai, T.; Fan, F.; Sato, K.; Shimizu, K.; Kawabe, Y.; Kamihira, M. Miniaturized skeletal muscle tissue fabrication for measuring contractile activity. J. Biosci. Bioeng. 2021, 131, 434–441. [Google Scholar] [CrossRef]
- Ito, A.; Yamamoto, Y.; Sato, M.; Ikeda, K.; Yamamoto, M.; Fujita, H.; Nagamori, E.; Kawabe, Y.; Kamihira, M. Induction of functional tissue-engineered skeletal muscle constructs by defined electrical stimulation. Sci. Rep. 2014, 4, 4781. [Google Scholar] [CrossRef] [Green Version]
- Okita, K.; Matsumura, Y.; Sato, Y.; Okada, A.; Morizane, A.; Okamoto, S.; Hong, H.; Nakagawa, M.; Tanabe, K.; Tezuka, K.; et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 2011, 8, 409–412. [Google Scholar] [CrossRef] [Green Version]
- Yoshioka, K.; Ito, A.; Kawabe, Y.; Kamihira, M. Novel neuromuscular junction model in 2D and 3D myotubes co-cultured with induced pluripotent stem cell-derived motor neurons. J. Biosci. Bioeng. 2020, 129, 486–493. [Google Scholar] [CrossRef]
- Kennedy, K.A.M.; Porter, T.; Mehta, V.; Ryan, S.D.; Price, F.; Peshdary, V.; Karamboulas, C.; Savage, J.; Drysdale, T.A.; Li, S.; et al. Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin. BMC Biol. 2009, 7, 67. [Google Scholar] [CrossRef] [Green Version]
- Pawlowski, M.; Ortmann, D.; Bertero, A.; Tavares, J.M.; Pedersen, R.A.; Vallier, L.; Kotter, M.R.N. Inducible and deterministic forward programming of human pluripotent stem cells into neurons, skeletal myocytes, and oligodendrocytes. Stem Cell Rep. 2017, 8, 803–812. [Google Scholar] [CrossRef] [Green Version]
- Langelaan, M.L.P.; Boonen, K.J.M.; Rosaria-Chak, K.Y.; van der Schaft, D.W.J.; Post, M.J.; Baaijens, F.P.T. Advanced maturation by electrical stimulation: Differences in response between C2C12 and primary muscle progenitor cells. J. Tissue Eng. Regen. Med. 2011, 5, 529–539. [Google Scholar] [CrossRef] [PubMed]
- Kanzleiter, T.; Rath, M.; Görgens, S.W.; Jensen, J.; Tangen, D.S.; Kolnes, A.J.; Kolnes, K.J.; Lee, S.; Eckel, J.; Schürmann, A.; et al. The myokine decorin is regulated by contraction and involved in muscle hypertrophy. Biochem. Biophys. Res. Commun. 2014, 450, 1089–1094. [Google Scholar] [CrossRef] [PubMed]
- Miura, T.; Kishioka, Y.; Wakamatsu, J.; Hattori, A.; Hennebry, A.; Berry, C.J.; Sharma, M.; Kambadur, R.; Nishimura, T. Decorin binds myostatin and modulates its activity to muscle cells. Biochem. Biophys. Res. Commun. 2006, 340, 675–680. [Google Scholar] [CrossRef] [PubMed]
- Kawahara, Y.; Yamaoka, K.; Iwata, M.; Fujimura, M.; Kajiume, T.; Magaki, T.; Takeda, M.; Ide, T.; Kataoka, K.; Asashima, M.; et al. Novel electrical stimulation sets the cultured myoblast contractile function to ‘on’. Pathobiology 2006, 73, 288–294. [Google Scholar] [CrossRef]
- Schill, K.E.; Altenberger, A.R.; Lowe, J.; Periasamy, M.; Villamena, F.A.; Rafael-Fortney, J.A.; Devor, S.T. Muscle damage, metabolism, and oxidative stress in mdx mice: Impact of aerobic running. Muscle Nerve 2016, 54, 110–117. [Google Scholar] [CrossRef]
- Morgan, J.E.; Prola, A.; Mariot, V.; Pini, V.; Meng, J.; Hourde, C.; Dumonceaux, J.; Conti, F.; Relaix, F.; Authier, F.-J.; et al. Necroptosis mediates myofibre death in dystrophin-deficient mice. Nat. Commun. 2018, 9, 3655. [Google Scholar] [CrossRef]
- Constantin, B.; Sebille, S.; Cognard, C. New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: Implications in DMD. J. Muscle Res. Cell Motil. 2006, 27, 375–386. [Google Scholar] [CrossRef]
- Kyrychenko, V.; Poláková, E.; Janíček, R.; Shirokova, N. Mitochondrial dysfunctions during progression of dystrophic cardiomyopathy. Cell Calcium 2015, 58, 186–195. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Csordás, G.; Madesh, M.; Antonsson, B.; Hajnóczky, G. tcBid promotes Ca2+ signal propagation to the mitochondria: Control of Ca2+ permeation through the outer mitochondrial membrane. EMBO J. 2002, 21, 2198–2206. [Google Scholar] [CrossRef] [Green Version]
- Desagher, S.; Osen-Sand, A.; Nichols, A.; Eskes, R.; Montessuit, S.; Lauper, S.; Maundrell, K.; Antonsson, B.; Martinou, J.C. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 1999, 144, 891–901. [Google Scholar] [CrossRef] [PubMed]
- Abdel-Salam, E.; Abdel-Meguid, I.; Korraa, S.S. Markers of degeneration and regeneration in Duchenne muscular dystrophy. Acta Myol. 2009, 28, 94–100. [Google Scholar]
- Yokota, T.; Lu, Q.; Partridge, T.; Kobayashi, M.; Nakamura, A.; Takeda, S.; Hoffman, E. Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann. Neurol. 2009, 65, 667–676. [Google Scholar] [CrossRef] [PubMed]
- Aoki, Y.; Nakamura, A.; Yokota, T.; Saito, T.; Okazawa, H.; Nagata, T.; Takeda, S. In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse. Mol. Ther. 2010, 18, 1995–2005. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yoshioka, K.; Ito, A.; Horie, M.; Ikeda, K.; Kataoka, S.; Sato, K.; Yoshigai, T.; Sakurai, H.; Hotta, A.; Kawabe, Y.; et al. Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy. Cells 2021, 10, 2556. https://doi.org/10.3390/cells10102556
Yoshioka K, Ito A, Horie M, Ikeda K, Kataoka S, Sato K, Yoshigai T, Sakurai H, Hotta A, Kawabe Y, et al. Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy. Cells. 2021; 10(10):2556. https://doi.org/10.3390/cells10102556
Chicago/Turabian StyleYoshioka, Kantaro, Akira Ito, Masanobu Horie, Kazushi Ikeda, Sho Kataoka, Keiichiro Sato, Taichi Yoshigai, Hidetoshi Sakurai, Akitsu Hotta, Yoshinori Kawabe, and et al. 2021. "Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy" Cells 10, no. 10: 2556. https://doi.org/10.3390/cells10102556